Paper · 10167
B cell tolerance induced by polymeric antigens. I. Comparison of the dose and epitope density requirements for inactivation of primed and unprimed B cells in vivo.
Klaus GG and 1 other. Eur J Immunol, 1976. Cited by 35 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. B cell tolerance induced by polymeric antigens. I. Comparison of the dose and epitope density requirements for inactivation of primed and unprimed B cells in vivo. Papers, record 10167. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10167
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- B cell tolerance induced by polymeric antigens. I. Comparison of the dose and epitope density requirements for inactivation of primed and unprimed B cells in vivo.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Haptens | Major topic |
| Immune Tolerance | Major topic |
| Animals | |
| Dinitrobenzenes | |
| Dose-Response Relationship, Immunologic | |
| Female | |
| Hemocyanins | |
| Immunologic Memory | |
| Male | |
| Mice | |
| Polysaccharides, Bacterial | |
| Streptococcus pneumoniae | |
| Structure-Activity Relationship |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,977,606 | A mathematical model of B lymphocyte differentiation: control by antigen. | J Math Biol | 1981 | https://conductscience.org/library/papers/6977606 | PubMed |
| 6,209,210 | Induction of tolerance by haptenated liposomes carrying mouse erythrocyte membrane glycoprotein. | Immunology | 1984 | https://conductscience.org/library/papers/6209210 | PubMed |
| 6,201,438 | Hapten-specific B cell blockade of the immune response to a thymus-independent-1 antigen produced by concomitant administration of a thymus-independent-2 antigen. | Immunology | 1984 | https://conductscience.org/library/papers/6201438 | PubMed |
| 6,172,369 | Induction and persistence of B-cell tolerance to the thymus-dependent component of the alpha(1 leads to 6) glucosyl determinant of dextran. Recovery induced by treatment with dextranase in vivo. | Immunology | 1981 | https://conductscience.org/library/papers/6172369 | PubMed |
| 3,917,979 | Immunity and protection of mice against Neisseria meningitidis group B by vaccination, using polysaccharide complexed with outer membrane proteins: a comparison with purified B polysaccharide. | Infect Immun | 1985 | https://conductscience.org/library/papers/3917979 | PubMed |
| 1,087,122 | The acquisition of b-cell competence and diversity. | Am J Pathol | 1976 | https://conductscience.org/library/papers/1087122 | PubMed |
| 1,086,883 | Allogeneic carrier-specific enhancement of hapten-specific secondary B-cell responses. | J Exp Med | 1976 | https://conductscience.org/library/papers/1086883 | PubMed |
| 389,783 | Studies on B-cell memory. II. T-cell independent antigen can induce B-cell memory. | Immunology | 1979 | https://conductscience.org/library/papers/389783 | PubMed |
| 342,401 | Differential tolerance of thymus-independent and thymus-dependent antibody responses. | Immunology | 1978 | https://conductscience.org/library/papers/342401 | PubMed |
| 308,090 | Cellular and molecular requirements for X-linked, hapten-specific B-cell blockade in CBA/N mice. | J Exp Med | 1978 | https://conductscience.org/library/papers/308090 | PubMed |
1 to 10 of 12
See all 12 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10167
GET https://conductscience.org/api/papers/v1/10167/authors